financetom
Business
financetom
/
Business
/
V2X Clinches $4.3 Billion US Air Force Deal For T-6 Support
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
V2X Clinches $4.3 Billion US Air Force Deal For T-6 Support
Aug 1, 2025 10:09 AM

V2X, Inc. ( VVX ) has secured a $4.3 billion contract from the U.S. Air Force to provide Contractor Operated and Maintained Base Supply (COMBS) services for the T-6 aircraft program.

This initiative is designed to enhance the availability and safety of aircraft used for pilot training across multiple military branches.

The contract, structured as an indefinite-delivery/indefinite-quantity agreement, covers supply chain management to ensure aircraft meet daily operational and depot maintenance needs for the U.S. Air Force, Navy, and Army.

Also Read: Defense Stocks Head Into Earnings At Record Highs — Is The Boom Just Beginning?

The Department of Defense emphasizes this approach as a key strategy for aligning military procurement with modern commercial standards.

Jeremy C. Wensinger, president and CEO of V2X, expressed gratitude for the opportunity, stating, "This contract reflects the dedication of our team and the pride we take in supporting the readiness of our nation’s aircraft." He noted that the contract represents the company's ongoing commitment to supporting the operational readiness of U.S. military aircraft.

Vinny Caputo, senior vice president of aerospace systems at V2X, added that the company's expertise in supply chain operations would ensure consistent delivery of parts and services.

Lockheed Martin Corp. ( LMT ) and Boeing Co. ( BA ) are two major defense contractors operating in similar aerospace and military support sectors.

The contract work will be executed at various military bases across the United States and is slated to continue through July 2034, further cementing V2X's role as a key partner in supporting the U.S. defense infrastructure.

Price Action: VVX shares are trading higher by 0.084% to $47.34 at last check, Friday.

Read Next:

Bitcoin Plummets To $115,000, Ethereum, XRP, Dogecoin Follow Lower

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Moderna Allegedly Misled Investors on RSV Vaccine's Efficacy, Lawsuit Says
Update: Moderna Allegedly Misled Investors on RSV Vaccine's Efficacy, Lawsuit Says
Aug 12, 2024
02:16 PM EDT, 08/12/2024 (MT Newswires) -- (Updates with Moderna's ( MRNA ) response and latest stock movement in the last two paragraphs.) Moderna ( MRNA ) allegedly made false and/or misleading statements and failed to disclose that its mRNA respiratory syncytial virus, or RSV, vaccine was less effective than it had previously led investors to believe, according to a...
US SEC sues over alleged $650 million global crypto fraud
US SEC sues over alleged $650 million global crypto fraud
Aug 12, 2024
NEW YORK (Reuters) - The U.S. Securities and Exchange Commission on Monday sued the cryptocurrency company NovaTech and its married co-founders, saying they fraudulently raised over $650 million from more than 200,000 investors worldwide, including many Haitian-Americans. NovaTech and co-founders Cynthia and Eddy Petion allegedly promised investors their money would be safe, with Cynthia Petion assuring they would be in...
Oragenics Shares Rise After Study Shows No DNA Damage From Concussion Drug Candidate
Oragenics Shares Rise After Study Shows No DNA Damage From Concussion Drug Candidate
Aug 12, 2024
02:22 PM EDT, 08/12/2024 (MT Newswires) -- Oragenics ( OGEN ) shares surged nearly 16% in recent Monday trading after the company said its concussion treatment candidate, dubbed ONP-002, has completed a study showing it does not cause deoxyribonucleic acid, or DNA, damage or genotoxicity in animals. The study tested ONP-002 over several days in low, medium, and high doses....
MarketWise Drops Over 25% After CEO Resigns: Sale Of His Porter & Co. To Company 'Like Trying To Share A Ham Sandwich With A Pit Bull'
MarketWise Drops Over 25% After CEO Resigns: Sale Of His Porter & Co. To Company 'Like Trying To Share A Ham Sandwich With A Pit Bull'
Aug 12, 2024
Porter Stansberry resigns as chairman and CEO of MarketWise ( MKTW ), causing a 25% drop in stock. He blames legal issues for not completing sale of his company to MarketWise ( MKTW ).MarketWise Inc. ( MKTW ) shares plummeted more than 25% since its founder Porter Stansberry announced on X on Friday evening he was resigning from the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved